Fasciola hepatica is the mammalian liver parasite and it produces the result of poor welfare and economic losses in ruminants. While the number of eggs stool is the most common test used for diagnosis, it does not indicate a migration of the adult stage. serological techniques improve the sensitivity at all stages of liver fluke infection. The purpose of this study was to compare four commercially available ELISA test for the diagnosis of F. hepatica.
To this end, we tested three types of samples; (I) is known F. hepatica Status sera from experimental infection for the comparison of sensitivity and specificity, (ii) sera from pre- and post-flukicide-treated (albendazole, closantel, nitroxynil and triclabendazole) beef cattle seropositive for contrast difference before and after treatment, and (iii) samples of bulk tank milk samples from dairy cattle during periods of exposure to high and low F. hepatica to assess seasonal variation with four tests available.
Samples were assayed using ELISA kit provided by four manufacturers (Ildana Biotech, IDEXX, Svanova, and Bio-X). Samples were analyzed simultaneously and in duplicate.In Ildana population control, IDEXX and Bio-X presented 100% sensitivity (Se) and specificity (Sp), Svanovir served Se and Sp of 59% from 96%. In flukicide-treated beef, kit highlighted a decrease in antibody levels 90 days post-treatment in variable degrees.
Finally, bulk milk showed a significant decrease in the value of ELISA between periods of high and low exposure to coincidence with all tests and Sp studied.Se found in this study, confirming that Ildana, IDEXX and Bio-X accurate for detecting exposure to F. hepatica in cattle Ireland. Svanovir Se and Sp in this population, suggesting that larger studies are needed to confirm the characteristics of these tests in the herd of Ireland.
In the use of post-treatment, Bio-X showed a consistent and significant reduction of the value of the ELISA in all treatment groups, which were shown to be a reliable tool to assess the effects of treatment on day 90 post-treatment. Finally, all tests showed to be a reliable tool for monitoring F. hepatica high season and low exposure, using bulk tank milk samples.
Comparison of four commercially available ELISA kits for diagnosis of Fasciola hepatica in Irish cattle.
Improved diagnosis of diabetes type Japanese-onset autoimmune first time using a new ELISA kit GADAb, compared to the previously used GADAb RIA kit.
We compared the results of glutamic acid decarboxylase antibody test (GADAb) using radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) in subjects with age-onset diabetes mellitus type 1 specimen (T1D) .Serum collected from 1024 cases of Japan (426 laki- male and 598 female) in 2013. the average age of diagnosis was 7 years (0-18 years).
Blood specimen obtained at a mean age of 13 years (2-22 years) .Among 628 subjects whose serum specimens collected within 5 years after diagnosis, positive GADAb level is 47.9% and 69.4% using a RIA using ELISA. The subjects were divided into four groups according to their RIA and ELISA results for GADAb as follows: Gr I (RIA + / ELISA +), Gr II (RIA + / ELISA-), Gr III (RIA- / ELISA +) and Gr IV (RIA – / ELISA-).
Clinical characteristics and genetic Gr Gr I and III were very similar in terms of age at diagnosis, male / female ratio, a relatively high positive rate for both IA-2AB and ZnT8Ab, and HLA genotype. Gr II only contains 5 patients and is characterized by a younger age at diagnosis, a low positive rate for both IA-2AB and ZnT8Ab and unique HLA genotype.
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381198-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-002mgWithBSAAzideat02mgmL
MyBiosource
0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-01mgWithBSAAzideat02mgmL
MyBiosource
0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-01mgWithoutBSAAzideat1mgmL
MyBiosource
0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-5x01mgWithBSAAzideat02mgmL
MyBiosource
5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
Traumatic Brain Injury Biomarker Antibody Sampler Kit
HAK21057
HUABIO
1 Kit
Ask for price
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-002mgWithBSAAzideat02mgmL
MyBiosource
0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-01mgWithBSAAzideat02mgmL
MyBiosource
0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-01mgWithoutBSAAzideat1mgmL
MyBiosource
0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-5x01mgWithBSAAzideat02mgmL
MyBiosource
5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-002mgWithBSAAzideat02mgmL
MyBiosource
0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-01mgWithBSAAzideat02mgmL
MyBiosource
0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-01mgWithoutBSAAzideat1mgmL
MyBiosource
0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-5x01mgWithBSAAzideat02mgmL
MyBiosource
5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725
YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL
BNUM2759-50
Biotium
1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL
BNUM2760-50
Biotium
1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL
BNUB2759-100
Biotium
1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL
BNUB2759-500
Biotium
1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL
BNUB2760-100
Biotium
1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL
BNUB2760-500
Biotium
1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-002mgWithBSAAzideat02mgmL
MyBiosource
0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-01mgWithBSAAzideat02mgmL
MyBiosource
0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-01mgWithoutBSAAzideat1mgmL
MyBiosource
0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-5x01mgWithBSAAzideat02mgmL
MyBiosource
5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-002mgWithBSAAzideat02mgmL
MyBiosource
0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-01mgWithBSAAzideat02mgmL
MyBiosource
0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-01mgWithoutBSAAzideat1mgmL
MyBiosource
0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-5x01mgWithBSAAzideat02mgmL
MyBiosource
5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-5x01mgWithoutBSAAzideat1mgmL
MyBiosource
5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL
BNUM2430-50
Biotium
1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL
BNUB2430-100
Biotium
1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL
BNUB2430-500
Biotium
1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 1mg/mL
BNUM2570-50
Biotium
1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL
BNUB2570-100
Biotium
1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL
BNUB2570-500
Biotium
1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL
BNCB2759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL
BNCB2759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL
BNCB2760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL
BNCB2760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL
BNC682759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL
BNC682759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL
BNC682760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL
BNC682760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL
BNC942759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL
BNC942759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL
BNC942760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL
BNC942760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL
BNC472759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL
BNC472759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL
BNC472760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL
BNC472760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL
BNC882759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL
BNC882759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL
BNC882760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL
BNC882760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL
BNC402759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL
BNC402759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL
BNC402760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL
BNC402760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL
BNC042759-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL
BNC042759-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL
BNC042760-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL
BNC042760-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 1mg/mL
BNUM1943-50
Biotium
1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL
BNUB1943-100
Biotium
1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL
BNUB1943-500
Biotium
1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042430-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042430-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042570-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042570-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL
BNCB1943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL
BNCB1943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL
BNC681943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL
BNC681943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL
BNC881943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL
BNC881943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL
BNC941943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL
BNC941943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL
BNC401943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL
BNC401943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL
BNC471943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL
BNC471943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL
BNC041943-100
Biotium
1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL
BNC041943-500
Biotium
1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
Her-2 IHC Bio-marker control TMA
Her2a
TissueArray
each
EUR 78
Description: Her-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including TNM, clinical stage and pathology grade, 10 cases/ 10 cores, replaced by Her2b
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b
HER2c
BioCoreUSA
row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case
MELISA-TEK® High Sensitivity Extraction Kit
510391
ELISA Technologies
96 Well
Ask for price
Bovine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich
EK11F897
BioVenic
Ask for price
Ask for price
Porcine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich
EK12F771
BioVenic
Ask for price
Ask for price
Porcine Cardiac Troponin I (TNNI3) ELISA Kit-Sandwich
EK12F459
BioVenic
Ask for price
Ask for price
Sheep Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich
EK10F934
BioVenic
Ask for price
Ask for price
Horse Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich
EK11F90
BioVenic
Ask for price
Ask for price
Canine Troponin T2, Cardiac Type (TNNT2) ELISA Kit-Sandwich
EK12F992
BioVenic
Ask for price
Ask for price
Canine Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich
EK11F169
BioVenic
Ask for price
Ask for price
Feline Troponin T2 Cardiac Type (TNNT2) ELISA Kit-Sandwich
EK11F260
BioVenic
Ask for price
Ask for price
Feline Troponin I3, Cardiac Type (TNNI3) ELISA Kit-Sandwich
EK8F243
BioVenic
Ask for price
Ask for price
Porcine Troponin T2 Cardiac Type (TNNT2) ELISA Kit-Sandwich
EK9F605
BioVenic
Ask for price
Ask for price
Rat Myosin-binding protein C, cardiac-type,Cardiac MyBP-C ELISA Kit
EK5119
SAB
96 tests
EUR 739
Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit
MBS9428945-5x96Tests
MyBiosource
5x96Tests
EUR 3385
Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit
MBS9428945-96Tests
MyBiosource
96Tests
EUR 735
Bovine Troponin I, Cardiac Muscle (TNNI3) ELISA Kit-Sandwich
EK11F592
BioVenic
Ask for price
Ask for price
Bovine Troponin T, Cardiac Muscle (TNNT2) ELISA Kit-Sandwich
EK11F594
BioVenic
Ask for price
Ask for price
Rat Cardiac Troponin ELISA Kit
MBS3809733-10x96StripWells
MyBiosource
10x96-Strip-Wells
EUR 6725
Rat Cardiac Troponin ELISA Kit
MBS3809733-48StripWells
MyBiosource
48-Strip-Wells
EUR 550
Rat Cardiac Troponin ELISA Kit
MBS3809733-5x96StripWells
MyBiosource
5x96-Strip-Wells
EUR 3420
Rat Cardiac Troponin ELISA Kit
MBS3809733-96StripWells
MyBiosource
96-Strip-Wells
EUR 765
Mouse Troponin I Type 3, Cardiac (TNNI3) ELISA Kit-Sandwich
EK5F306
BioVenic
Ask for price
Ask for price
Mouse Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich
EK6F148
BioVenic
Ask for price
Ask for price
Chicken Troponin I, Cardiac Muscle (TNNI3) ELISA Kit-Sandwich
EK3F426
BioVenic
Ask for price
Ask for price
Rabbit Troponin I Type 3, Cardiac (TNNI3) ELISA Kit-Sandwich
EK3F206
BioVenic
Ask for price
Ask for price
Rabbit Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich
EK3F222
BioVenic
Ask for price
Ask for price
Equine Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich
EK1F111
BioVenic
Ask for price
Ask for price
Human Cardiac Troponin ELISA Kit
MBS3804762-10x96StripWells
MyBiosource
10x96-Strip-Wells
EUR 6725
Human Cardiac Troponin ELISA Kit
MBS3804762-48StripWells
MyBiosource
48-Strip-Wells
EUR 550
Human Cardiac Troponin ELISA Kit
MBS3804762-5x96StripWells
MyBiosource
5x96-Strip-Wells
EUR 3420
Human Cardiac Troponin ELISA Kit
MBS3804762-96StripWells
MyBiosource
96-Strip-Wells
EUR 765
Pig Cardiac phospholamban ELISA Kit
MBS288942-10x96StripWells
MyBiosource
10x96-Strip-Wells
EUR 4630
Pig Cardiac phospholamban ELISA Kit
MBS288942-48StripWells
MyBiosource
48-Strip-Wells
EUR 440
Pig Cardiac phospholamban ELISA Kit
MBS288942-5x96StripWells
MyBiosource
5x96-Strip-Wells
EUR 2480
Pig Cardiac phospholamban ELISA Kit
MBS288942-96StripWells
MyBiosource
96-Strip-Wells
EUR 580
Dog Cardiac phospholamban ELISA Kit
MBS2887029-10x96StripWells
MyBiosource
10x96-Strip-Wells
EUR 4630
Dog Cardiac phospholamban ELISA Kit
MBS2887029-48StripWells
MyBiosource
48-Strip-Wells
EUR 440
Dog Cardiac phospholamban ELISA Kit
MBS2887029-5x96StripWells
MyBiosource
5x96-Strip-Wells
EUR 2480
If the positive rate of both IA-2AB or ZnT8Ab or both are added to the results GADAb using RIA, autoimmune T1D percentage increased from 47.9% to 78.5% .the diagnosis of autoimmune time-onset T1D Japan GADAb increased when the results obtained using the new ELISA method , compared with RIA method previously used.